Haley K. Perlow, MD retweeted
Replying to @RadOncUH
@RadOncUH PGY-4 @QingLi_MDPhD 🔥crushing it with an(other) 🎤oral presentation this morning on her #HolmanPathway work on how RT modulates HER2 expression and trastuzuman deruxtecan response in HER2 low metastatic breast cancer.
#bcsm @TyMillerLab
Haley K. Perlow, MD retweeted
Replying to @ASTRO_org
@ASTRO_org #ASTRO26 trial data ➡️how we approach 🧠mets from SCLC has officially, fundamentally changed.
🤔Want to know how to put @SWOG MAVERICK & @NRGonc CC009 together?
🎧Listen to our @NRGonc podcast about BOTH trials with Chad Rusthoven!
👉🏼 tinyurl.com/muhkda7t
#btsm
Haley K. Perlow, MD retweeted
#ASTRO26
So proud of Janice Lyons, our leader of breast cancer @RadOncUH giving a thoughtful discussion during today’s plenary.
So lucky to have you on the team!
@lauren_henke @angela_jia_ @PranshuMohindra @HaleyPerlow @KashaniRojano @Soum_Roy_RadOnc
Full house at our @RadOncUH #ASTRO2026 Meet & Greet! 🎯☢️
So much fun meeting the next generation of #RadOnc and introducing them to our residents and faculty. Thanks to everyone who came out—we may have taken over Flight Club just a little 💙
Haley K. Perlow, MD retweeted
Cognition sparing SRS compared to N0574/N107C SRS
COG-SRS better all-domains cognitive outcomes, especially language
#ASTRO26 abstract #280 sciencedirect.com/science/ar…
Haley K. Perlow, MD retweeted
Yet there appears to be heading on the meaning of the trial itself clearly positive for DFS and should be the standard of care the toxicity profile here is much better than many of our drug trials. One caveat this is without PET which would have been a better discriminator
Haley K. Perlow, MD retweeted
Important results for the ROAM trial, primary endpoint met DFS DFS significantly improved with adjuvant RT FOR GTR grade 2 meningioma. Subgroup for molecular still positive.
thelancet.com/journals/lance…
Well that didn’t take long! 1 of our newest physics residents, Olivia Magneson, is already award winning! Major congrats on the Early Career Investigator award for the POWV-ORV AAPM meeting for work on dose response w/ MR fingerprinting w/ mentors @tedandahalf @HaleyPerlow ⚡️🎉
Calling all MS4s & future #RadOnc residents headed to #ASTRO2026! ☢️ #Match2027
Come hang with the @RadOncUH crew for drinks + apps (our treat!) at Flight Club Boston 🎯
📅 Sun 9/28 | 4:30–6 PM
👉🏼 Register: forms.gle/xTPPBFvA1YTwwaKW7
Haley K. Perlow, MD retweeted
The Pike Lab at @MSK_RadOnc has 13 abstracts at the upcoming @ASTRO_org 2026 AGM. Come check out how we are advancing the management of brain metastases.
Haley K. Perlow, MD retweeted
Annual @RadOncUH resident brunch at our house: great food by @APrice_BeamOn, better people, @angela_jia_ blatantly cheating @CodenamesGame, & an impromptu non-birthday celebration complete with singing AND 2 cakes. 🎂🎂 Strong team. Questionable board game ethics. 10/10 Saturday.
🚨📢Calling all MS4s or prospective residents going to #ASTRO2026 in Boston! Join our residency crew for Happy Hour with drinks and apps (our treat!) on Sunday, Sept 28th from 4:30-6:00pm EST @ The Flight Club Boston! ⚡️
Register here 👉🏼forms.gle/xTPPBFvA1YTwwaKW7 – at University Heights, OH
Haley K. Perlow, MD retweeted
Sparing Memory with Advanced Radiosurgical Targeting (SMART) SRS
· Replan SIMT SRS plans using SMART patients >10 brain mets
· Better sparing hippos, amygdala, fornix, corpus callosum
· Cognitive effects of SMART SRS unknown, future studies needed
NBD just a DOZEN of our @radoncuh physicians recognized as Cleveland’s Top Docs 2026 by @castle_connolly & @clevelandmagazine ! Congrats to this crew, we love to see so many of our team recognized by their peers this way. Team-wide clinical excellence! #topdocs2026
We are now enrolling patients in the Athena 2 trial comparing HA-WBRT to MA-WBRT! Open at @RadOncUH in Cleveland, opening soon at Ohio State.
Check out our phase 2 trial using Memory avoidant (MA)WBRT, improved cognitive preservation compare to historical HA-WBRT. Out now in Neuro Onc advances
academic.oup.com/noa/advance…
Haley K. Perlow, MD retweeted
Check out our phase 2 trial using Memory avoidant (MA)WBRT, improved cognitive preservation compare to historical HA-WBRT. Out now in Neuro Onc advances
academic.oup.com/noa/advance…
Haley K. Perlow, MD retweeted
Replying to @HaleyPerlow @QingLi_MDPhD @TyMillerLab @DrSpratticus @KashaniRojano @lauren_henke @angela_jia
and @TeddyA_MedPhys presenting a poster demonstrating the efficacy of MRI fingerprinting to detect changes in brain neurocognitive substructures. Both representing @RadOncUH well and very proud to work with them. @DrSpratticus @KashaniRojano @lauren_henke @angela_jia.
Congratulations to @QingLi_MDPhD presenting on radiation enhancing the efficacy of HER2 ADCs as an oral presentation at the ASCO/SNO CNS Metastasis 2026 Conference. @TyMillerLab @DrSpratticus @KashaniRojano @lauren_henke @angela_jia.
and @TeddyA_MedPhys presenting a poster demonstrating the efficacy of MRI fingerprinting to detect changes in brain neurocognitive substructures. Both representing @RadOncUH well and very proud to work with them. @DrSpratticus @KashaniRojano @lauren_henke @angela_jia.
Haley K. Perlow, MD retweeted
Congratulations to @QingLi_MDPhD presenting on radiation enhancing the efficacy of HER2 ADCs as an oral presentation at the ASCO/SNO CNS Metastasis 2026 Conference. @TyMillerLab @DrSpratticus @KashaniRojano @lauren_henke @angela_jia.

































